07/18/2012 - 11:18am

Mylan has settled a patent litigation suit filed by Somaxon Pharmaceutical concerning an insomnia drug, Mylan said.

07/17/2012 - 12:44pm

Watson Pharmaceuticals confirmed it received a request for additional information from the Federal Trade Commission in connection with the drug maker's pending acquisition of Actavis Group.

07/16/2012 - 5:17pm

Prescription drug counterfeiting got significant attention in March 2011 when CBS News’ “60 Minutes” reported on the problem, including a tour of a drug counterfeiting operation.


07/16/2012 - 5:17pm

Several policy-makers and companies have sought ways to confront the problem of prescription drug abuse. Last month, New York Gov. Andrew Cuomo announced a plan — calling it the first in the country — to create an all-
electronic registry that would enable doctors, pharmacists and law enforcement to track controlled substances to prevent excessive prescription and refill requests.

07/16/2012 - 3:12pm

An affiliate of private investment firm TPG will acquire Par Pharmaceutical Cos., the drug maker said Monday.

07/16/2012 - 3:02am

A subsidiary of Par Pharmaceutical Cos. acquired earlier this year has received its first Food and Drug Administration approval.

07/13/2012 - 3:53pm

The main office of the Food and Drug Administration in charge of regulating generic drugs has appointed a new director, the agency said Friday.

07/13/2012 - 9:54am

The Food and Drug Administration has approved a generic contraceptive made by Watson Pharmaceuticals, the drug maker said Friday.

07/12/2012 - 9:58am

The Food and Drug Administration has approved a generic drug for arthritis made by Watson Pharmaceuticals, the company said.